Corporacio Sanitaria Parc Tauli
Sabadell 8208
3 studies enrolling now · 21 studies all time
What they study most
Active Psoriatic Arthritis, Ankylosing Spondylitis, Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Cancer of the Prostate, Cholangiocarcinoma, Crohn's Disease, Cystic Fibrosis, Deep Venous Thrombosis, Gastric Cancer, HER2-amplified Biliary Tract Cancers, Hormone Sensitive Prostate Cancer
Studies at this site
- A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease — Recruiting now
- A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis — Recruiting now
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — Recruiting now
- Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) — Running, not enrolling
- A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE — Stopped early
- A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer — Completed
- A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
- A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE — Stopped early
- An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. — Completed
- A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers — Completed
- A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
- Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder — Completed
- A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer — Completed
- PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer — Stopped early
- A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
- An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus — Completed
- Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa Bacteria — Stopped early
- Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy — Stopped early
- Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) — Completed
- Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis — Completed
- Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis — Completed